Treatment of chronic hepatitis C with PEGylated interferon and ribavirin.

Current gastroenterology reports

Volumn 4, Issue 1, 2002, Pages 23-30

  Cornberg, Markus ^a   Wedemeyer, Heiner ^a   Manns, Michael P ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA2A INTERFERON; ALPHA2B INTERFERON; ANTIVIRUS AGENT; MACROGOL DERIVATIVE; PEGINTERFERON ALFA-2A; PEGINTERFERON ALFA-2B; PEGINTERFERON ALPHA2A; PEGINTERFERON ALPHA2B; RIBAVIRIN; VIRUS RNA;

CLINICAL TRIAL; DOSE RESPONSE; DRUG COMBINATION; GENETICS; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; REVIEW;

ANTIVIRAL AGENTS; CLINICAL TRIALS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG THERAPY, COMBINATION; HEPACIVIRUS; HEPATITIS C, CHRONIC; HUMANS; INTERFERON ALFA-2A; INTERFERON ALFA-2B; POLYETHYLENE GLYCOLS; RIBAVIRIN; RNA, VIRAL;

EID: 0036483611     PISSN: 15228037     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11894-002-0034-y     Document Type: Review

References (26)